class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
Limited independent clinical evidence for superior efficacy claims. Orotic acid accumulation at very high doses: fatty liver (animal data at extreme doses). Generally safe at typical supplement doses. Less evidence than citrate or bisglycinate forms.
Calcium salt of orotic acid. Promoted for superior brain penetration. Evidence base limited and contested. More expensive than conventional calcium forms.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)